STRUCTURAL UNCERTAINTY IN COST-EFFECTIVENESS MODELS OF TREATMENT FOR ALZHEIMER'S DISEASE

被引：0
|
作者：
Peters, J. L. [1 ]
Hoyle, M. [1 ]
Anderson, R. [1 ]
机构：
[1] Peninsula Med Sch, Exeter, Devon, England
来源：
VALUE IN HEALTH | 2010年 / 13卷 / 07期
关键词：
D O I：
10.1016/S1098-3015(11)71850-2
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A240 / A240
页数：1
相关论文
共 50 条
  • [1] Structural and parameter uncertainty in Bayesian cost-effectiveness models
    Jackson, Christopher H.
    Sharples, Linda D.
    Thompson, Simon G.
    [J]. JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES C-APPLIED STATISTICS, 2010, 59 : 233 - 253
  • [2] Effectiveness and Cost-Effectiveness of the Pharmacological Treatment of Alzheimer's Disease and Vascular Dementia
    Versijpt, Jan
    [J]. JOURNAL OF ALZHEIMERS DISEASE, 2014, 42 : S19 - S25
  • [3] COST-EFFECTIVENESS OF DONEPEZIL IN THE TREATMENT OF PATIENTS WITH ALZHEIMER'S DISEASE: AN UPDATE
    Chyr, L. C.
    Yapici, H. O.
    Padula, W., V
    [J]. VALUE IN HEALTH, 2018, 21 : S206 - S206
  • [4] Cost-Effectiveness of Donepezil in the Treatment of Mild or Moderate Alzheimer's Disease
    Lopez-Bastida, Julio
    Hart, Warren
    Garcia-Perez, Lidia
    Linertova, Renata
    [J]. JOURNAL OF ALZHEIMERS DISEASE, 2009, 16 (02) : 399 - 407
  • [5] Cost-effectiveness of donepezil in the treatment of mild or moderate Alzheimer's disease
    Neumann, PJ
    Hermann, RC
    Kuntz, KM
    Araki, SS
    Duff, SB
    Leon, J
    Berenbaum, PA
    Goldman, PA
    Williams, LW
    Weinstein, MC
    [J]. NEUROLOGY, 1999, 52 (06) : 1138 - 1145
  • [6] The Cost-Effectiveness of Olanzapine Treatment for Agitation and Psychosis in Alzheimer's Disease
    Kirbaeh, Stephanie E.
    Simpson, Kit N.
    Nietert, Paul J.
    Mintzer, Jacobo E.
    [J]. AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2008, 16 (03): : A71 - A72
  • [7] Handling Uncertainty in Cost-Effectiveness Models
    Andrew H. Briggs
    [J]. PharmacoEconomics, 2000, 17 : 479 - 500
  • [8] Handling uncertainty in cost-effectiveness models
    Briggs, AH
    [J]. PHARMACOECONOMICS, 2000, 17 (05) : 479 - 500
  • [9] Modeling cost-effectiveness of pharmaceuticals in Alzheimer's disease
    Oremus, Mark
    Tarride, Jean-Eric
    [J]. EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2012, 12 (03) : 275 - 277
  • [10] COST-EFFECTIVENESS OF DONEPEZIL IN ALZHEIMER'S DISEASE IN SWEDEN
    Mesterton, J.
    By, A.
    Sandelin, R.
    Jonsson, L.
    [J]. VALUE IN HEALTH, 2009, 12 (07) : A369 - A369
12345